Juvéderm™ dermal filler, a ‘next generation’ hyaluronic acid dermal filler approved by the FDA in June 2006, contains the highest concentration of cross-linked hyaluronic acid of any dermal filler currently available. These attributes provide optimal results with a single treatment of Juvéderm™ in the majority of patients and deliver sustained results for up to six months or longer. Juvéderm™ is an excellent treatment option for:
- Lip enhancement
- Deep folds
- Facial lines
- Wrinkle correction
- Volume augmentation of the lips
- Shaping facial contours (such as cheeks and chin correcting)
- Smile lines (correcting thin, superficial lines around the eyes, mouth and forehead)
Juvéderm™ is now formulated with lidocaine to minimize any injection discomfort. Patients voted a huge YES to the preference of lidocaine-enhanced fillers. Juvederm XC = Extra Comfort
New Study Results: At 24 weeks, 96 percent of nasolabial folds treated with Juvederm had maintained clinically significant correction, and 81 percent maintained the correction for 1 year or more. Results were similar for those subjects with follow-up through 48 weeks after repeated treatment. The median volume required for repeated treatment with Juvederm was significantly less than that for initial treatment (0.7 ml versus 1.6 ml). Article from Jan 2008 American Society of Plastic Surgeons Journal.
In addition, Juvéderm™ dermal filler is the only hyaluronic acid dermal filler developed using a proprietary, technologically advanced manufacturing process that results in a malleable smooth gel that flows easily into the skin, creating a smooth, natural look and feel. All other currently approved hyaluronic acid dermal fillers utilize a gel particle suspension formulation.
Juvéderm™ dermal filler can be administered in a smooth-flowing injection, providing physicians with a high level of control for individualized, tailored facial contouring and for achieving a smooth and natural look.